DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Eris Lifesciences Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 1 hr ago·10 Aug 2026, 9:11 am

Eris Lifesciences

Eris Lifesciences Limited has informed stock exchanges that it is scheduled to hold an institutional investor meet or conference call. This announcement signals that the company intends to engage directly with analysts and large investors to discuss its business performance and future outlook.

For investors, such meetings are a key opportunity to gain clarity on the company's strategic direction and operational health. It provides a platform for management to address market concerns and share updates that may not be fully reflected in the public financial reports.

Investors should watch for any specific guidance provided by management regarding sales targets, product launches, or cost management strategies during the event. These insights can be crucial for assessing the company's growth trajectory in the near future.